Informatie: Dit is niet de actueelste versie van het datamodel. Een versieoverzicht vindt u links onder Versies. De actueelste versie vindt u hier.
Informatie:
Fout:
ID
19948
Beschrijving
An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: AVA100468, Sponsor: GSK
Trefwoorden
Versies (2)
- 31-01-17 31-01-17 -
- 06-02-17 06-02-17 -
Geüploaded op
31 januari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Study Conclusion GSK-AVA100468 NCT00381238
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Similar models
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item
Did the subject become pregnant during the study? (Check that responses provided correspond with the sex of the subject) If `Yes`, complete Pregnancy Notification
integer
C0032961 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study? (Check that responses provided correspond with the sex of the subject) If `Yes`, complete Pregnancy Notification
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (not of childbearing potential or male) (3)
End Date
Item
Date of subject completion or withdrawal
date
C0806020 (UMLS CUI [1])
Withdrawal
Item
Was the subject withdrawn from the study?
boolean
C2349954 (UMLS CUI [1])
Item
What was the primary reason for withdrawal?
integer
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (5)
CL Item
Non-compliance (6)
CL Item
Other (7)
Withdrawal Other
Item
What was the primary reason for withdrawal? If other, specify:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])